Midatech Pharma

LN: MTPH

£52.8m market cap

39.5p last close

Midatech Pharma is an ambitious speciality pharmaceutical company, founded in 2000. The patented gold nanoparticle technology platform is developing therapeutics for several diseases such as diabetes and various cancers.

Investment summary

Edison Investment Research is terminating coverage on Midatech Pharma (MTPH). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Sector
Healthcare
Share price graph
Key management
Stephen Stamp CEO and CFO